NorthX Biologics is providing expert plasmid DNA solutions for all phases ranging from early pre-clinical through to commercial manufacture. We offer a range of plasmid qualities with the right level of control for every purpose, ensuring efficient expedition of your program with full regulatory compliance. We are providing pDNA as critical starting material for viral vector gene therapies and mRNA applications but also complete drug product manufacturing including aseptic fill/finish for pDNA vaccines and other modalities.
By applying our flexible proprietary platform process we can deliver high quality plasmids with compressed timelines facilitating speed to market. We are using aligned processes ensuring scalability from small to large scale with full in-house analytical support. In our modern innovation labs, we are providing full development services to meet you specific needs for optimization and process adaptions. By applying a structured R&D model we help to mitigate later manufacturing risks.
NorthX Biologics is a CDMO and Innovation Hub in Advanced Biologics, with +30 years of GMP production experience. The team provides process development and GMP manufacturing services with expertise in plasmid DNA, mRNA, proteins, cells and other advanced biologics. Headquartered in the heart of Sweden, the team serves customers worldwide and in 2021 was recognized as a national innovation hub for advanced therapeutics and vaccines. NorthX Biologics has the ambition to become a leading cell and gene therapy manufacturer and partner of choice for innovative drug development companies.
Janet Hoogstraate, CEO of NorthX Biologics, recently appeared in an episode of BEYOND TOMORROW, a podcast by Plantvision. Janet discusses challenges and opportunities within Swedish pharmaceutical manufacturing, with a special focus on ...
Outer membrane vesicles (OMVs) and extracellular vesicles (EVs) are revolutionizing biopharmaceuticals, offering cutting-edge vaccines and therapeutic delivery solutions. These nanoscale vesicles hold immense potential to enhance immune responses and serve ...
Neoantigen cancer vaccines represent a groundbreaking advancement in personalized medicine, offering tailored cancer treatments designed for each patient’s unique tumor profile. These therapies require rapid turnaround from tumor identification to ...